ActivePure Medical Shares Study Results on Safety and Efficacy
ActivePure Medical, a division of AP Sciences Group, LLC, stands at the forefront of innovative air and surface decontamination technologies. Recently, the company released significant findings from a comprehensive safety study surrounding its Advanced Photohydrolysis Technology. The results, published in a reputable scientific journal, illustrate the technology's safety when utilized in occupied indoor settings, reinforcing its role in promoting healthier environments.
The Necessity of Advanced Safety Technologies
In light of recent public health demands, the need for effective and continuous air cleaning systems has never been more acute. ActivePure Technology, notably featured in devices such as the Induct Guardian Series, has already proved its worth by effectively reducing airborne pathogens. A relevant study in a medical journal showed remarkable results, including a dramatic reduction of methicillin-resistant Staphylococcus aureus (MRSA) by nearly 99%. Such evidence underscores the critical place of ActivePure’s technology in today's health landscape.
Innovative Study Methodology
The newly released safety study complements previous efficacy research by validating the safe and continuous use of the ActivePure Advanced Photohydrolysis Technology. This robust 90-day investigation utilized C57BL murine models, chosen for their biological similarities to humans. Throughout the study, researchers observed several health metrics, including behavior patterns, weight gain, food consumption, and blood chemistry, all while performing detailed analyses of respiratory tissues.
Expert Insights and Findings
Leading the study was Dr. Claude P. Selitrennikoff, who emphasized the study's implications for public health safety. Dr. Selitrennikoff noted, "The thorough analysis of respiratory tissues revealed no adverse physiological impacts following continuous exposure. Innovations like ActivePure are vital for ensuring safer indoor environments, especially amid global health challenges." Key findings showcased no significant differences in the monitored indicators between exposed and control mice, solidifying the safety stance of ActivePure Technology.
Contributions to Public Health
Joseph P. Urso, CEO of AP Sciences Group, stated, "ActivePure Technology’s efficacy is well-documented through rigorous testing and real-world application outcomes. This research offers vital assurance regarding the safety of technologies employed to safeguard health." Such assurance is paramount as public entities and individuals alike seek reliable solutions to mitigate health risks.
About ActivePure Medical
ActivePure Medical is recognized globally for its pioneering role in proactive air and surface decontamination solutions tailored for healthcare environments. The company's signature ActivePure Advanced Photohydrolysis Technology works to neutralize various indoor contaminants efficiently and continuously. By mimicking natural processes occurring in the atmosphere, this technology provides persistent protection against environmental hazards without needing human intervention.
Technological Advancements and Impact
This revolutionary approach addresses volatile organic compounds (VOCs) while ensuring that no harmful ozone is produced, making it suitable for constant use in occupied areas. Originally developed for space missions, the technology has evolved to significantly mitigate the risk of exposure to a range of pathogens—including bacteria and viruses—by over 99% in both the air and on surfaces. Its versatility spans multiple environments, including hospitals, long-term care facilities, and commercial buildings.
ActivePure Advanced Photohydrolysis Technology: A Closer Look
This innovative technology employs a unique honeycomb matrix along with a specialized UV light source, facilitating a reaction that produces potent oxidative molecules capable of neutralizing a vast array of contaminants. Its ongoing protection ensures that both air quality and surface cleanliness are maintained effectively. Studies have validated the technology's high efficacy, marking reductions of pathogenic organisms like MRSA and other healthcare-associated infections (HAIs).
Frequently Asked Questions
What is ActivePure Medical known for?
ActivePure Medical specializes in advanced air and surface decontamination technology, prioritizing safety and health in occupied spaces.
How effective is ActivePure Technology in reducing airborne pathogens?
The technology has demonstrated over a 99% efficacy rate in reducing various pathogens, including MRSA, in controlled studies.
What type of technology does ActivePure utilize?
ActivePure employs Advanced Photohydrolysis Technology, which integrates a honeycomb matrix and UV light to create powerful oxidative molecules.
What were the findings of the recent safety study?
The recent study showed no adverse physiological effects in murine models exposed to ActivePure technology, supporting its safety for continuous use.
How does ActivePure Technology ensure safety in occupied spaces?
The technology effectively reduces airborne contaminants without producing harmful byproducts, making it safe for regular use in various environments.
